Addus HomeCare Co. Forecasted to Post Q4 2022 Earnings of $0.91 Per Share (NASDAQ:ADUS)

Addus HomeCare Co. (NASDAQ:ADUSGet Rating) – Investment analysts at William Blair reduced their Q4 2022 earnings per share (EPS) estimates for shares of Addus HomeCare in a report released on Tuesday, August 2nd. William Blair analyst M. Larew now forecasts that the company will post earnings of $0.91 per share for the quarter, down from their prior forecast of $0.93. The consensus estimate for Addus HomeCare’s current full-year earnings is $3.19 per share.

Addus HomeCare (NASDAQ:ADUSGet Rating) last issued its earnings results on Monday, August 1st. The company reported $0.91 earnings per share for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.01). The firm had revenue of $236.94 million for the quarter, compared to the consensus estimate of $238.40 million. Addus HomeCare had a net margin of 4.90% and a return on equity of 8.63%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the firm earned $0.78 earnings per share.

Several other research analysts have also issued reports on ADUS. Royal Bank of Canada reduced their target price on Addus HomeCare from $111.00 to $110.00 and set an “outperform” rating on the stock in a research report on Wednesday. Stephens dropped their price target on Addus HomeCare from $110.00 to $101.00 and set an “overweight” rating on the stock in a research note on Tuesday, June 21st. Stifel Nicolaus initiated coverage on Addus HomeCare in a research note on Tuesday, June 28th. They set a “buy” rating and a $101.00 price target on the stock. Oppenheimer dropped their price target on Addus HomeCare from $135.00 to $130.00 and set an “outperform” rating on the stock in a research note on Wednesday. Finally, Bank of America initiated coverage on Addus HomeCare in a research note on Wednesday, April 13th. They issued a “buy” rating and a $110.00 target price on the stock. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, Addus HomeCare has an average rating of “Buy” and an average target price of $110.40.

Addus HomeCare Trading Down 2.6 %

ADUS opened at $92.69 on Thursday. The firm has a market cap of $1.49 billion, a price-to-earnings ratio of 33.58, a PEG ratio of 2.62 and a beta of 0.85. The company has a current ratio of 2.00, a quick ratio of 2.65 and a debt-to-equity ratio of 0.33. Addus HomeCare has a 12 month low of $68.57 and a 12 month high of $108.11. The stock has a fifty day moving average price of $85.97 and a 200-day moving average price of $83.18.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors have recently made changes to their positions in the stock. Maryland State Retirement & Pension System boosted its position in shares of Addus HomeCare by 2.1% during the 1st quarter. Maryland State Retirement & Pension System now owns 6,442 shares of the company’s stock worth $601,000 after purchasing an additional 130 shares in the last quarter. Advisor Group Holdings Inc. boosted its position in shares of Addus HomeCare by 9.1% in the 4th quarter. Advisor Group Holdings Inc. now owns 1,783 shares of the company’s stock worth $167,000 after buying an additional 149 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Addus HomeCare by 1.8% in the 1st quarter. Envestnet Asset Management Inc. now owns 8,938 shares of the company’s stock worth $834,000 after buying an additional 159 shares in the last quarter. Assetmark Inc. boosted its position in shares of Addus HomeCare by 110.1% in the 2nd quarter. Assetmark Inc. now owns 374 shares of the company’s stock worth $31,000 after buying an additional 196 shares in the last quarter. Finally, Argent Capital Management LLC boosted its position in shares of Addus HomeCare by 3.1% in the 2nd quarter. Argent Capital Management LLC now owns 7,295 shares of the company’s stock worth $608,000 after buying an additional 222 shares in the last quarter. 96.04% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, EVP David W. Tucker sold 2,080 shares of the firm’s stock in a transaction on Friday, July 15th. The stock was sold at an average price of $90.00, for a total transaction of $187,200.00. Following the completion of the transaction, the executive vice president now directly owns 8,468 shares in the company, valued at $762,120. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other news, EVP David W. Tucker sold 2,080 shares of the business’s stock in a transaction that occurred on Friday, July 15th. The shares were sold at an average price of $90.00, for a total transaction of $187,200.00. Following the completion of the sale, the executive vice president now owns 8,468 shares in the company, valued at approximately $762,120. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael D. Wattenbarger sold 1,718 shares of the business’s stock in a transaction that occurred on Tuesday, May 24th. The stock was sold at an average price of $85.00, for a total transaction of $146,030.00. Following the sale, the executive vice president now owns 7,012 shares of the company’s stock, valued at approximately $596,020. The disclosure for this sale can be found here. Over the last three months, insiders sold 3,940 shares of company stock worth $344,102. Company insiders own 4.50% of the company’s stock.

Addus HomeCare Company Profile

(Get Rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Earnings History and Estimates for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.